| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/14/2006 | US20060204983 Binding assay using binding agents with tail groups |
| 09/14/2006 | US20060204982 Novel compositions and methods for cancer |
| 09/14/2006 | US20060204981 Compositions for modulation of PARP and methods for screening for same |
| 09/14/2006 | US20060204980 Colorectal cancer therapies |
| 09/14/2006 | US20060204978 Methods for isolation of nucleic acids from prokaryotic spores |
| 09/14/2006 | US20060204977 oligonucleotides used for detection and analyzing analytes in solution |
| 09/14/2006 | US20060204976 Multivalent avian influenza vaccines |
| 09/14/2006 | US20060204975 Markers for cyclin dependent kinase inhibitors |
| 09/14/2006 | US20060204974 Screening agents for post-transcriptional control of angiotensin receptors; hypotensive agents |
| 09/14/2006 | US20060204973 Methods for synthesizing polynucleotides using a single primer |
| 09/14/2006 | US20060204972 Systems and methods for determining real-time PCR cycle thresholds using a rotation transformation |
| 09/14/2006 | US20060204971 Oligonucleotides for multiplexed binding assays |
| 09/14/2006 | US20060204970 Using oligonucleotide sequences based on the Mycobacterium tubercluosis rpoB gene by comparing hybridization patterns of target nucleic organism to hybridization patterns in a database; diagnosis of drug resistance in HIV patients |
| 09/14/2006 | US20060204969 Genetic variations (SNPs) adjacent to the AKT1 gene locus, and diagnostic and prognostic uses thereof |
| 09/14/2006 | US20060204968 Tools for diagnostics, molecular definition and therapy development for chronic inflammatory joint diseases |
| 09/14/2006 | US20060204967 Methods for identifying risk of breast cancer and treatments thereof |
| 09/14/2006 | US20060204966 selecting therapy for a human subject having a solid epithelial tumor that overexpresses ErbB2 comprising determining whether the tumor expresses p95ErbB2; reversible dual tyrosine kinase inhibitor of both ErbB2 and epidermal growth factor receptor |
| 09/14/2006 | US20060204965 Using allelic profile of frizzled-related protein (FRZB) as prognostic tool in predicting bone and eating disorders |
| 09/14/2006 | US20060204964 Molecular detection systems utilizing reiterative oligonucleotide synthesis |
| 09/14/2006 | US20060204963 Nucleotide sequences of coryneform bacteria coding for proteins involved in l-serine metabolism and method for producing l-serine |
| 09/14/2006 | US20060204962 Genetic polymorphisms as predictive diagnostics for adverse drug reactions (adr) and drug efficacy |
| 09/14/2006 | US20060204961 Reagents and methods for diagnosis of attention deficit hyperactivity disorder |
| 09/14/2006 | US20060204960 Method for diagnosing diffuse-type gastric cancers |
| 09/14/2006 | US20060204959 Solid support having electrostatic layer and use thereof |
| 09/14/2006 | US20060204958 Methods for diagnosing htlv-i-mediated diseases |
| 09/14/2006 | US20060204957 Mta1s, a steriod hormone receptor corepressor |
| 09/14/2006 | US20060204956 Method for detection of hTR and hTERT telomerase-associated RNA in plasma or serum |
| 09/14/2006 | US20060204955 Method for the production of bacterial toxins |
| 09/14/2006 | US20060204954 Compositions and methods for binding agglomeration proteins |
| 09/14/2006 | US20060204953 Method and apparatus for automated analysis of biological specimen |
| 09/14/2006 | US20060204952 Technique for measuring cell-membrane properties in cultured cells grown on biomaterials in an Ussing chamber |
| 09/14/2006 | US20060204951 Platelet biomarkers for the detection of disease |
| 09/14/2006 | US20060204513 Novel surface protein (hbsag) variant of the hepatitis b virus |
| 09/14/2006 | US20060204510 Bv8 nucleic acids and polypeptides with mitogenic activity |
| 09/14/2006 | US20060204490 Hemostatic compositions containing sterile thrombin |
| 09/14/2006 | US20060204439 Administering isotope labeled water to tissue; measurement, calibration |
| 09/14/2006 | US20060204401 Device and method for multiple analyte detection |
| 09/14/2006 | US20060202179 Chemiluminescent Acridinium Compounds and Analogues thereof as Substrates of Hydrolytic Enzymes |
| 09/14/2006 | US20060201881 Capillary-channeled polymeric fiber as solid phase extraction media |
| 09/14/2006 | US20060201810 Automated laboratory system |
| 09/14/2006 | US20060201805 Electrodes on support; mediator is 1,10-phenanthroline-5,6-dione; for detecting an analyte in a sample; accurate clinical response |
| 09/14/2006 | US20060200982 Method of making a biosensor |
| 09/14/2006 | US20060200981 Method of making a biosensor |
| 09/14/2006 | DE102005011421A1 Bestimmung von kurzkettiger SRL-Alkoholdehydrogenase (DHRS4) als Biomarker für Entzündungen und Infektionen Determination of short-chain SRL alcohol (DHRS4) as a biomarker for inflammation and infection |
| 09/14/2006 | DE102005011398A1 Verfahren zur Untersuchung von Cytosin-Methylierungen in DNA A method for the examination of cytosine methylations in DNA |
| 09/14/2006 | DE102005010418A1 Use of oligopeptide containing cysteine for modifying growth of pathogens or substrate utilization of rhizosphere organisms, particularly for diagnosis of pathogens |
| 09/14/2006 | CA2603711A1 Infectious, chimeric hepatitis c virus, methods of producing the same and methods of use thereof |
| 09/14/2006 | CA2600907A1 Coagulation and fibrinolytic cascades modulator |
| 09/14/2006 | CA2600677A1 Association between markers in the leptin gene and carcass traits in commercial feedlot steer and heifers |
| 09/14/2006 | CA2600675A1 Use of a combination of myxoma virus and rapamycin for therapeutic treatment |
| 09/14/2006 | CA2600412A1 Viral diagnostic method and well for use in same |
| 09/14/2006 | CA2600240A1 Method for preparing polynucleotides for analysis |
| 09/14/2006 | CA2600132A1 Stabilizing enzyme activity in electrochemical biosensors |
| 09/14/2006 | CA2600129A1 Enhancing a luminescent signal |
| 09/14/2006 | CA2600113A1 Pharmaceutical liposomal compositions |
| 09/14/2006 | CA2600093A1 Proteomic methods using sart stressed animals |
| 09/14/2006 | CA2600024A1 Diagnostic and therapeutic target for macular degeneration |
| 09/14/2006 | CA2599647A1 Processes using dual specificity oligonucleotide and dual specificity oligonucleotide |
| 09/14/2006 | CA2599577A1 Nucleic acids and proteins and methods for making and using them |
| 09/14/2006 | CA2599080A1 Genetic variants increase the risk of age-related macular degeneration |
| 09/14/2006 | CA2597255A1 Natural ligand of g protein coupled receptor rcc356 and uses thereof |
| 09/13/2006 | EP1701275A2 PCR elbow determination by rotational transform |
| 09/13/2006 | EP1701163A1 Fluorescence polarization assays involving polyions |
| 09/13/2006 | EP1700922A2 Nitroindole derivatives and labeled oligonucleotide probes containing them |
| 09/13/2006 | EP1700921A2 Regulation of a human asparagine-hydroxylase |
| 09/13/2006 | EP1700920A1 Synthetic antibiotics |
| 09/13/2006 | EP1700919A1 Biosensor having soil microorganism housed therein and use thereof |
| 09/13/2006 | EP1700915A2 Enzymatic DNA molecules |
| 09/13/2006 | EP1700914A1 Development of mammalian genome modification technique using retrotransposon |
| 09/13/2006 | EP1700913A1 Fluorescent proteins |
| 09/13/2006 | EP1700912A1 Method of detecting target molecule by using aptamer |
| 09/13/2006 | EP1700911A1 In vitro method for disassembly/reassembly of papillomavirus virus-like particles (VLPs) |
| 09/13/2006 | EP1700867A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/13/2006 | EP1700849A1 Photo-activatable amino acids |
| 09/13/2006 | EP1700245A1 A method, an installation and a computer program for estimating the initial size of a population of nucleic acidsm in particular by pcr |
| 09/13/2006 | EP1700127A1 Method of enhancing signal detection of cell-wall components of cells |
| 09/13/2006 | EP1700126A1 Staphylococcus detection |
| 09/13/2006 | EP1700122A2 Immunoassays, haptens, immunogens and antibodies for anti-hiv therapeutics |
| 09/13/2006 | EP1700117A1 Method and kit for pesticide analysis |
| 09/13/2006 | EP1699939A1 Method of detecting mutations associated with thrombosis |
| 09/13/2006 | EP1699937A2 Predicting response and outcome of metastatic breast cancer anti-estrogen therapy |
| 09/13/2006 | EP1699936A2 Universal amplification of fragmented rna |
| 09/13/2006 | EP1699935A1 Use of a mutation in the braf gene for the determination of the malignancy of melanoma cells |
| 09/13/2006 | EP1699934A2 Soluble analyte detection and amplification |
| 09/13/2006 | EP1699933A1 Composition for binding a nucleic acid to a solid phase |
| 09/13/2006 | EP1699929A1 Insect resistant cotton plants and methods of detecting the same |
| 09/13/2006 | EP1699925A1 Il-23 and its receptor; related reagents and methods |
| 09/13/2006 | EP1699832A2 Site selectively tagged and templated molecularly imprinted polymers for sensor applications |
| 09/13/2006 | EP1699827A1 Antibody inhibiting uracil-dna-glycosylase and uses thereof for decontaminating nucleic acid amplification reactions |
| 09/13/2006 | EP1699825A2 Methods for identifying functional antibodies |
| 09/13/2006 | EP1699824A2 Ztnf 12, a tumor necrosis factor |
| 09/13/2006 | EP1699481A2 Methods and compositions comprising bacteriophage nanoparticles |
| 09/13/2006 | EP1699420A1 Membranes incorporating recognition moieties |
| 09/13/2006 | EP1699413A2 Nucieic acid amplification methods |
| 09/13/2006 | EP1699282A2 Compositions and methods for detecting reverse transciptase in a sample |
| 09/13/2006 | EP1623018A4 Mptens as modifiers of the pten/igf pathway and methods of use |
| 09/13/2006 | EP1594991B1 Method of producing recombinant dna molecules |
| 09/13/2006 | EP1570078A4 Molecular sub-classification of kidney tumors and the discovery of new diagnostic markers |
| 09/13/2006 | EP1552009A4 Method for identifying cellular growth inhibitors |
| 09/13/2006 | EP1543149A4 High resolution analysis of genetic variation within cryptosporidium parvum |